Sanofi Current Ratio 2006-2018 | SNY

Current and historical current ratio for Sanofi (SNY) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Sanofi current ratio for the three months ending March 31, 2018 was 0.00.
Sanofi Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-03-31 $0.00B $0.00B 0.00
2017-12-31 $29.79B $17.47B 1.71
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $29.78B $18.76B 1.59
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $29.53B $18.19B 1.62
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $25.23B $17.22B 1.47
2016-03-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $24.35B $18.03B 1.35
2014-06-30 $27.94B $19.48B 1.43
2013-06-30 $27.17B $17.80B 1.53
2012-06-30 $27.56B $20.66B 1.33
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $29.05B $18.92B 1.54
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $32.57B $23.10B 1.41
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $35.96B $15.62B 2.30
2010-09-30 $0.00B $0.00B 0.00
2010-06-30 $31.89B $15.40B 2.07
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $33.30B $17.29B 1.93
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $25.23B $14.69B 1.72
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $22.66B $13.75B 1.65
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $18.62B $14.01B 1.33
2008-03-31 $0.00B $0.00B 0.00
2007-12-31 $17.21B $13.25B 1.30
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $16.75B $13.18B 1.27
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $15.28B $12.91B 1.18
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $15.45B $17.89B 0.86
2006-03-31 $0.00B $0.00B 0.00
2005-12-31 $16.34B $19.20B 0.85
2005-09-30 $0.00B $0.00B 0.00
2005-06-30 $16.55B $20.53B 0.81
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $112.036B $39.599B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.911B 18.42
Pfizer (PFE) United States $259.128B 14.61
Merck (MRK) United States $201.621B 17.47
Novartis AG (NVS) Switzerland $201.503B 17.22
AbbVie (ABBV) United States $132.506B 11.76
Eli Lilly (LLY) United States $121.525B 21.36
Novo Nordisk (NVO) Denmark $106.636B 17.32
AstraZeneca (AZN) United Kingdom $102.177B 12.69
GlaxoSmithKline (GSK) United Kingdom $100.760B 13.54
Bristol-Myers Squibb (BMY) United States $87.355B 14.39